The list of the Top 10 Innovations of 2011 were revealed by ‘The Scientist’, in which the M2 compact high-performance MRI imaging system from Aspect Imaging was one of the recipients of this award.
According to Aspect Imaging's Founder and CEO, Uri Rapoport, the firm is pleased about the selection of its M2 imaging platform being placed among the 'Top 10 Innovations' in life science by The Scientist and its panel of jury. R&D customers benefit from the firm's M2 platform with the progress in M2 MRI system utilization and the adoption of its technology worldwide. M2 high-performance compact MRI system facilitates life scientists to quantify disease expression, to examine disease evolution and to evaluate its response in vivo and therapeutic efficacy. Hence, the award is an additional recognition to the value of MRI.
Aspect Imaging is a pioneer in high-performance compact MRI imaging systems for clinical, preclinical, and other industrial applications. In preclinical research, the M2 platform and its related products are being introduced by pharmaceutical companies with the intent to replace the complex, traditional MRI systems. This platform from Aspect provides an improved approach to researchers for all biological questions in a simplified, speedy and economic manner. The M2 is portable as the system lacks fringe magnetic field. The M2 platform has wide application in vitro, in vivo, and ex vivo besides being used for high-resolution 3D molecular, functional, anatomical, and multi-modality imaging. This high-performance MRI system of Aspect Imaging is vital for several laboratories and hospitals as it has an extended application in the field of medicine and life science including diagnosis and treatment of disease is an efficient way.